Novo Nordisk bought Forma Therapeutics Forma Therapeutics Holdings from 10/14/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Novo Nordisk bought Forma Therapeutics for $1.1 billion, or $20 a share.

Forma Therapeutics Holdings

Review

Source:

{source} pictogram

ir.formatherapeutics.com

Vladimir Petenev

News editor

Write your comment first

News feed

Government supported the split of Transneft shares

10/17/23 TRNFP

Bank of America reported for 9 months of 2023

10/17/23 BAC

TGC-14 power plants increased energy generation by 5%

10/17/23 TGKN

Johnson & Johnson reported for 9 months of 2023

10/17/23 JNJ

Alrosa denied reports of withdrawal from the Katoka project in Angola

10/17/23 ALRS

Hard discounter chain B1 has launched its first distribution center

10/17/23 MGNT

Yango has launched Arabic-speaking voice assistant Yasmina

10/17/23 YNDX

Alrosa negotiates exit from Katoka diamond mine

10/17/23 ALRS

Medsi opens Radiotherapy and Nuclear Medicine Center

10/17/23 AFKS

Passenger traffic on UTair aircraft increased by 9.4%

10/17/23 UTAR